Nystatin and Amicar drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Nystatin (nystatin) and Amicar (aminocaproic acid). Common drug interactions include ileus among females and dyspnoea among males.

The phase IV clinical study analyzes what interactions people have when they take Nystatin and Amicar. It is created by eHealthMe based on reports of 27 people who take the same drugs from the FDA, and is updated regularly.

What is Nystatin?

Nystatin has active ingredients of nystatin. It is often used in thrush. eHealthMe is studying from 33,568 Nystatin users. Check the latest studies of Nystatin.

What is Amicar?

Amicar has active ingredients of aminocaproic acid. eHealthMe is studying from 1,323 Amicar users. Check the latest studies of Amicar.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 30, 2026

27 people who take Nystatin and Amicar together, and have interactions are studied.

What are the common drug interactions of Nystatin and Amicar, by gender? *:

female:

Ileus (a painful obstruction of the ileum or other part of the intestine)
Influenza like illness
Intestinal infarction (intestinal tissue death)
Intracranial pressure increased (high pressure inside the skull and thus in the brain tissue and cerebrospinal fluid)
Leukopenia (less number of white blood cells in blood)
Mediastinal haemorrhage (bleeding in mediastinum)
Metabolic acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body)
Nausea (feeling of having an urge to vomit)
Neuroendocrine tumour (a tumour that forms from cells that release hormones into the blood in response to a signal from the nervous system)
Neutropenia (an abnormally low number of neutrophils)

male:

Dyspnoea (difficult or laboured respiration)
Renal failure acute (rapid kidney dysfunction)
Dysstasia (difficulty in standing)
Emotional distress
Fatigue (feeling of tiredness)
Gait disturbance
General physical health deterioration (weak health status)
Haemorrhage intracranial (bleeding within the skull)
Hypovolaemia (a decreased volume of circulating blood in the body)
Mobility decreased (ability to move is reduced)

What are the common drug interactions of Nystatin and Amicar, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

Asthenia (weakness)
Cardiomyopathy (weakening of the heart muscle)
Dyspnoea (difficult or laboured respiration)
Enterobacter pneumonia (lung inflammation caused by bacteria of the family enterobacteriaceae)
Epistaxis (bleed from the nose)
Heart rate decreased
Hyperglycaemia (high blood sugar)
Hypertension (high blood pressure)
Hypotension (abnormally low blood pressure)
Ileus (a painful obstruction of the ileum or other part of the intestine)

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Acute myeloid leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts)
Anaemia (lack of blood)
Arrhythmia (irregular heartbeat)
Ascites (accumulation of fluid in the abdominal cavity)
Bile duct stricture (narrowed areas of the bile ducts that can be either benign or malignant)
Cachexia (loss of weight)
Cardiac failure
Cd4 lymphocytes decreased
Chest pain
Cholecystitis (infection of gallbladder)

60+:

Death
Pneumonia
Acute myeloid leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts)
Anaemia (lack of blood)
Asthenia (weakness)
Blood calcium decreased
Blood magnesium decreased
Carbon dioxide decreased
Cough
Decreased appetite

What are the existing conditions these people have? *

Primary Myelofibrosis (primary disorder of the bone marrow): 4 people, 14.81%
Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 4 people, 14.81%
Multiple Myeloma (cancer of the plasma cells): 3 people, 11.11%
Anaemia Of Malignant Disease: 3 people, 11.11%
Type 2 Diabetes: 2 people, 7.41%
Thrombocytopenia (decrease of platelets in blood): 2 people, 7.41%
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets): 2 people, 7.41%
Idiopathic Thrombocytopenic Purpura (bleeding disorder in which the immune system destroys platelets, which are necessary for normal blood clotting): 2 people, 7.41%
Hyperlipidaemia (presence of excess lipids in the blood): 2 people, 7.41%
Hiv Infection: 2 people, 7.41%

* Approximation only. Some reports may have incomplete information.

Do you take Nystatin and Amicar?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously